Agenus, Inc. (AGEN)

4.79 +0.15 (+3.23%) USD  |  NASDAQ  |  Apr 17, 16:00
4.74 -0.05 (-1.04%) After-Hours: 05:22
More

Agenus SG&A Expense (Quarterly) : 12.30M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 3.74B
Protalix Biotherapeutics, Inc. 3.526M
West Pharmaceutical Services, Inc. 107.00M
CervoMed, Inc. 2.51M
Allogene Therapeutics, Inc. 13.77M